MedPath

Gb004, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:1
Completed:0

Trial Phases

2 Phases

Phase 1:1
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 2
1 (50.0%)

A Study With GB004 in Adult Subjects With Active Ulcerative Colitis (UC)

Phase 2
Terminated
Conditions
Ulcerative Colitis
Interventions
Drug: Placebo
First Posted Date
2020-09-21
Last Posted Date
2023-08-01
Lead Sponsor
GB004, Inc.
Target Recruit Count
236
Registration Number
NCT04556383
Locations
🇺🇸

B G Clinical Research, Inc., Encinitas, California, United States

🇺🇸

Gastro Care Institute, Lancaster, California, United States

🇺🇸

Texas Digestive Disease Consultants, Baton Rouge, Louisiana, United States

and more 74 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.